Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
Oral bioavailability has not been clearly measured in humans
The decision to use GLP-1 receptor agonists should be based on their licensed indications (diabetes or obesity management) rather than cholesterol lowering alone, with lipid improvements considered a beneficial additional effect within a comprehensive cardiovascular risk reduction strategy
Tirzepatide goes up to 15mg, and many people experience renewed weight loss at higher doses
Keep in mind that this table doesnt include all drugs that may interact with Zepbound
Your dose may increase over months if tolerance develops or weight loss plateaus
Effective medical weight management includes supervision, lab monitoring, nutrition guidance, and medication adjustments
